Immuneering - Class A (IMRX)'s 30-day implied volatility (IV30) was 46.8% at the close on October 22, 2026, down from 59.0% the day before, against a 52-week range of 46.0% to 221.8%. Its 20-day historical volatility was 53.2%.
Data as of October 22, 2026.